共 91 条
[1]
Morrow M(2020)Locoregional management after neoadjuvant chemotherapy J Clin Oncol 38 2281-2291
[2]
Khan AJ(2018)Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy Ann Surg Oncol 25 2596-2602
[3]
Nguyen TT(2020)Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer Ann Surg Oncol 27 4795-4801
[4]
Hoskin TL(2016)Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection J Clin Oncol 34 1072-1078
[5]
Day CN(2021)Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up Eur J Surg Oncol 47 804-812
[6]
Piltin MA(2016)How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study Ann Surg Oncol 23 3467-3474
[7]
Hoskin TL(2015)Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American college of surgeons oncology group Z1071 Trial (Alliance) J Clin Oncol. 33 3386-93
[8]
Day CN(2020)Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature Arch Gynecol Obstet. 301 341-53
[9]
Davis J(2019)Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: time trend, imaging staging power and nodal downstaging according to molecular subtype Eur J Surg Oncol 45 969-975
[10]
Boughey JC(2005)Role of ultrasound in the preoperative staging of patients with breast cancer Eur Radiol 15 1044-1050